{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:37:41Z","timestamp":1776443861341,"version":"3.51.2"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.physbeh.2008.02.009","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T19:08:28Z","timestamp":1204571308000},"page":"422-431","source":"Crossref","is-referenced-by-count":30,"title":["Endogenous opioids and cannabinoids: System interactions in the regulation of appetite, grooming and scratching"],"prefix":"10.1016","volume":"94","author":[{"given":"A.J.","family":"Tallett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Blundell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2008.02.009_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0304-3959(88)90085-1","article-title":"Itching after epidural and spinal opiates","volume":"33","author":"Ballantyne","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.physbeh.2008.02.009_bib2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/13543784.11.9.1189","article-title":"Anti-obesity drug development","volume":"11","author":"Bays","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.physbeh.2008.02.009_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2007.01.007","article-title":"Treatment of pruritus with topically applied opiate receptor antagonist","volume":"56","author":"Bigliardi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.jid.5700661","article-title":"Deletion of \u00b5- and \u03ba-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior","volume":"127","author":"Bigliardi-Qi","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.peptides.2004.01.006","article-title":"Endogenous opioids and feeding behavior: a 30-year historical perspective","volume":"25","author":"Bodnar","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2008.02.009_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1467-789X.2005.00218.x","article-title":"PYY3\u201336 as an anti-obesity drug target","volume":"6","author":"Boggiano","year":"2005","journal-title":"Obes Rev"},{"key":"10.1016\/j.physbeh.2008.02.009_bib7","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1056\/NEJMp030053","article-title":"Diet, obesity and cardiovascular risk","volume":"348","author":"Bonow","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.physbeh.2008.02.009_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.06.006","article-title":"Effects of the CB1 cannabinoid receptor inverse agonist AM251 on food intake and body weight in mice lacking \u03bc-opioid receptors","volume":"1108","author":"Chen","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2008.02.009_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainres.2003.12.004","article-title":"Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice","volume":"999","author":"Chen","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2008.02.009_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0165-6147(00)01664-3","article-title":"Pharmacotherapy of obesity: targets and perspectives","volume":"22","author":"Chiesi","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.physbeh.2008.02.009_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjp.0706756","article-title":"Opioid and cannabinoid receptors: friends with benefits or just close friends?","volume":"148","author":"Christie","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2146\/ajhp060453","article-title":"Treatment of cholestatic pruritus in children","volume":"64","author":"Cies","year":"2007","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.physbeh.2008.02.009_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7258(00)00105-4","article-title":"Anti-obesity drugs: a critical review of current therapies and future opportunities","volume":"89","author":"Clapham","year":"2001","journal-title":"Pharmac Ther"},{"key":"10.1016\/j.physbeh.2008.02.009_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2125.2001.01294.x","article-title":"Drug treatment of obesity: from past failures to future successes?","volume":"51","author":"Collins","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2004.07.009","article-title":"Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite","volume":"500","author":"Cooper","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib16","series-title":"Endorphins, Opiates and Behavioural Processes","first-page":"143","article-title":"Endorphins, opiates and food intake","author":"Cooper","year":"1988"},{"key":"10.1016\/j.physbeh.2008.02.009_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.physbeh.2008.02.009_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainresrev.2005.10.004","article-title":"Cannabinoids, opioids and eating behavior: the molecular face of hedonism?","volume":"51","author":"Cota","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.physbeh.2008.02.009_bib19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s007020070043","article-title":"Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in na\u00efve mice","volume":"107","author":"Darmani","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.physbeh.2008.02.009_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","article-title":"Endocannabinoid control of food intake and energy balance","volume":"8","author":"DiMarzo","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.physbeh.2008.02.009_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.289.2.187","article-title":"Years of life lost due to obesity","volume":"2869","author":"Fontaine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.physbeh.2008.02.009_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1345\/aph.10121","article-title":"Opioid antagonists in the treatment of opioid-induced constipation and pruritus","volume":"35","author":"Friedman","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.physbeh.2008.02.009_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(99)00170-3","article-title":"Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist","volume":"370","author":"Gallate","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nrd913","article-title":"G-protein-coupled receptor oligimerization and its potential for drug discovery","volume":"1","author":"George","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.physbeh.2008.02.009_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.299.5608.849","article-title":"Obesity drug pipeline is not so fat","volume":"299","author":"Gura","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2008.02.009_bib26","first-page":"283","article-title":"The psychopharmacology of appetite: targets for potential anti-obesity agents","volume":"3","author":"Halford","year":"2003","journal-title":"Curr Med Chem: CNS Agents"},{"key":"10.1016\/j.physbeh.2008.02.009_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(98)00032-X","article-title":"Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake","volume":"61","author":"Halford","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2008.02.009_bib28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1079857","article-title":"Obesity and the environment: where do we go from here?","volume":"299","author":"Hill","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2008.02.009_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0031-9384(03)00066-0","article-title":"Effects of systematic variation in presatiation and fasting on the behavioural satiety sequence in male rats","volume":"79","author":"Ishii","year":"2003","journal-title":"Physiol Behav"},{"key":"10.1016\/j.physbeh.2008.02.009_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.physbeh.2004.01.009","article-title":"Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats","volume":"81","author":"Ishii","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.physbeh.2008.02.009_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbr.2004.07.012","article-title":"Anorexia and weight loss in male rats 24\u00a0h following single dose treatment with orexin-1 receptor antagonist SB-334867","volume":"157","author":"Ishii","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.physbeh.2008.02.009_bib32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0091-3057(02)00938-3","article-title":"Interactions between the CB1 receptor agonist \u03949-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited","volume":"73","author":"Jarbe","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2008.02.009_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0091-3057(03)00168-0","article-title":"The cannabinoid receptor antagonist SR-141716 does not readily antagonise open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats","volume":"75","author":"J\u00e4rbe","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2008.02.009_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008877-200411000-00008","article-title":"(\u2212)-Adamantyl-\u03948-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open field behaviors and antagonism by SR-141716 in rats","volume":"15","author":"J\u00e4rbe","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pbb.2006.08.006","article-title":"Effects of CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats","volume":"85","author":"Jarbe","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2008.02.009_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008877-200509000-00004","article-title":"Endocannabinoids in the regulation of appetite and body weight","volume":"16","author":"Kirkham","year":"2005","journal-title":"Behav Pharmacol,"},{"key":"10.1016\/j.physbeh.2008.02.009_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1079\/095442201108729141","article-title":"Endogenous cannabinoids and appetite","volume":"14","author":"Kirkham","year":"2001","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.physbeh.2008.02.009_bib38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s002130000596","article-title":"Synergistic effects of opioid and cannabinoid antagonists on food intake","volume":"153","author":"Kirkham","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02255473","article-title":"Itch-scratch responses induced by opioids through central mu opioid receptors in mice","volume":"7","author":"Kuraishi","year":"2000","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.physbeh.2008.02.009_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2008.02.009_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1467-789X.2004.00133.x","article-title":"Obesity in children and young people: a crisis in public health","volume":"5","author":"Lobstein","year":"2004","journal-title":"Obesity Rev"},{"key":"10.1016\/j.physbeh.2008.02.009_bib42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","article-title":"Pharmacological and biochemical interactions between opioids and cannabinoids","volume":"20","author":"Manzanares","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.physbeh.2008.02.009_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.104.000497.","article-title":"G protein-coupled receptor dimerization: function and ligand pharmacology","volume":"66","author":"Milligan","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jjp.88.285","article-title":"Itch-associated response induced by experimental dry skin in mice","volume":"88","author":"Miyamoto","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib45","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","article-title":"Functional interaction between opioid and cannabinoid receptors in drug self-administration","volume":"21","author":"Navarro","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2008.02.009_bib46","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1210\/en.2005-0237","article-title":"Peptide YY3\u201336 and glucagon-like peptide-17\u201336 inhibit food intake additively","volume":"146","author":"Neary","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib47","unstructured":"NIH Obesity Research Task Force. 2004. http:\/\/www.obesityresearch.nih.gov."},{"key":"10.1016\/j.physbeh.2008.02.009_bib48","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.1082319","article-title":"A clinical view of the obesity problem","volume":"299","author":"Pi-Sunyer","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2008.02.009_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(02)01551-0","article-title":"Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats","volume":"442","author":"Pietras","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","article-title":"\u03bc-opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Rios","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0163-7258(01)00160-7","article-title":"G-protein-coupled receptor dimerization: modulation of receptor function","volume":"92","author":"Rios","year":"2001","journal-title":"Pharmac Ther"},{"key":"10.1016\/j.physbeh.2008.02.009_bib52","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.0953-816x.2001.01518.x","article-title":"SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats","volume":"13","author":"Rodgers","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.physbeh.2008.02.009_bib53","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1210\/en.2007-0898","article-title":"Combination therapy with amylin and PYY[3\u201336] in obese rodents: anorexigenic synergy and weight loss additivity","volume":"148","author":"Roth","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s002130100910","article-title":"Effects of the cannabinoid receptor antagonist SR141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats","volume":"159","author":"Rowland","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib55","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuropharm.2006.05.019","article-title":"Interactions between CB1 cannabinoid and \u03bc opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core","volume":"51","author":"Schoffelmeer","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib56","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.npp.1300720","article-title":"Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems","volume":"30","author":"Solinas","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib57","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1210\/en.2005-0473","article-title":"Peripheral extendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice","volume":"146","author":"Talsania","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbr.2007.10.005","article-title":"Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food","volume":"187","author":"Tallett","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.physbeh.2008.02.009_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-007-0880-2","article-title":"Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats","volume":"195","author":"Tallett","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/FBP.0b013e3282eff0a9","article-title":"Acute anorectic response to cannabinoid receptor antagonist\/inverse agonist AM 251 in rat: indirect behavioural mediation","volume":"18","author":"Tallett","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.physbeh.2008.02.009_bib61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-003-1485-z","article-title":"Cannabinoids: reward, dependence and underlying mechanisms \u2014 a review of recent preclinical data","volume":"169","author":"Tanda","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib62","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1345\/aph.18115","article-title":"Opioid antagonists in the treatment of pruritus from cholestatic liver disease","volume":"32","author":"Terra","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.physbeh.2008.02.009_bib63","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF02244199","article-title":"Faciliatory effect of \u03949-tetrahydrocannabinol on hypothalamically induced feeding","volume":"103","author":"Trojniar","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nature02665","article-title":"Does gut hormone PYY3\u201336 decrease food intake in rodents?","volume":"430","author":"Tschop","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2008.02.009_bib65","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2174\/092986706778201512","article-title":"Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation","volume":"13","author":"Tucci","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.physbeh.2008.02.009_bib66","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00213-003-1451-9","article-title":"The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine","volume":"168","author":"Verty","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2008.02.009_bib67","series-title":"Appetite and Body Weight. Integrative systems and the development of anti-obesity drugs","first-page":"323","article-title":"Preclinical developments in antiobesity drugs","author":"Vickers","year":"2007"},{"key":"10.1016\/j.physbeh.2008.02.009_bib68","unstructured":"Weiss SM. Pharmacological and behavioural examination of the defensive reactions of laboratory mice to the calls of the Tawny owl. PhD thesis, 1995, School of Psychology, University of Leeds."},{"key":"10.1016\/j.physbeh.2008.02.009_bib69","series-title":"Appetite and Body Weight. Integrative systems and the development of anti-obesity drugs","first-page":"327","article-title":"Clinical investigations of antiobesity drugs","author":"Wilding","year":"2007"},{"key":"10.1016\/j.physbeh.2008.02.009_bib70","first-page":"317","article-title":"Reversal of cannabinoid hyperphagia by naloxone but not dexfenfluramine","volume":"35","author":"Williams","year":"2000","journal-title":"Appetite"},{"key":"10.1016\/j.physbeh.2008.02.009_bib71","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0091-3057(01)00694-3","article-title":"Reversal of \u03949-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine","volume":"71","author":"Williams","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2008.02.009_bib72","series-title":"Report of a WHO consultation","article-title":"Obesity: preventing and managing the global epidemic","volume":"vol. 84","author":"World Health Organisation","year":"2000"},{"key":"10.1016\/j.physbeh.2008.02.009_bib73","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0149-7634(02)00041-6","article-title":"Opioid peptides and the control of human ingestive behaviour","volume":"26","author":"Yeomans","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.physbeh.2008.02.009_bib74","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.ijo.0803125","article-title":"A comparison of national estimates of obesity prevalence from the behavioral risk factor surveillance system and the national health and nutrition examination survey","volume":"30","author":"Yun","year":"2006","journal-title":"Int J Obesity"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938408000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938408000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T14:51:31Z","timestamp":1557327091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938408000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0031938408000668"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2008.02.009","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}